The yeast multidrug transporter Pdr5 of the plasma membrane is ubiquitinated prior to endocytosis and degradation in the vacuole  by Egner, Ralf & Kuchler, Karl
FEBS 16521 FEBS Letters 378 (1996) 177-181 
The yeast multidrug transporter Pdr5 of the plasma membrane is 
ubiquitinated prior to endocytosis and degradation in the vacuole 
Ralf Egner, Karl Kuchler* 
Department of Molecular Genetics, University and Biocenter Vienna, Dr. Bohr-Gasse 9/2, ,4-1030 Vienna, Austria 
Received 7November 1995; revised version received 4 December 1995 
Abstract We have recently demonstrated that the PdrS ATP 
binding cassette multidrug transporter is a short-lived protein, 
whose biogenesis involves cell surface targeting followed by endo- 
cytosis and delivery to the vacuole for proteolytic turnover 
[Egner, R., Mah6, Y., Pandjaitan, R., and Kuchler, K. (1995) 
Mol. Cell. Biol. 15, 5879-5887]. Using c-myc epitope-tagged 
ubiquitin, we now have shown that Pdr5 is a ubiquitinated plasma 
membrane protein in vivo. Ubiquitination of Pdr5 was detected 
in both wild type and conditional end4 mutants defective in endo- 
cytic vesicle formation. Likewise, the Ste6 a-factor pheromone 
transporter, which represents another short-lived ABC trans- 
porter whose turnover requires vacuolar proteolysis, was also 
found to be ubiquitinated, and ubiquitin-modified Ste6 massively 
accumulated in end4 mutants at the restrictive temperature. By 
contrast, the plasma membrane ATPase Pmal, a long-lived and 
metabolically very stable protein, was found not to be ubiquiti- 
nated. Our results imply a novel function for ubiquitin in protein 
trafficking and suggest hat ubiquitination of certain short-lived 
plasma membrane proteins may trigger their endocytic delivery 
to the vacuole for proteolytic turnover. 
Key words: Yeast; ABC transporter; Proteolysis; Ubiquitin; 
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1. Introduction 
The yeast Pdr5 ATP binding cassette (ABC) multidrug trans- 
porter is a integral plasma membrane protein [1,2] consisting 
of twelve predicted membrane spanning helices and two ATP 
binding domains putatively facing the cytoplasm [3,4]. Overex- 
pression of PDR5 leads to the development of multidrug resis- 
tance (MDR) to a variety of structurally and functionally unre- 
lated cytotoxic ompounds [3-6]. Thus, Pdr5 is a functional 
yeast counterpart [7] of mammalian Mdrl or P-glycoprotein 
that is associated with MDR development in tumor cells [8]. 
The steady state levels of Pdr5 in the plasma membrane are 
maintained by endocytosis and delivery of Pdr5 to the vacuole, 
where it is degraded in a proteinase A-dependent manner [2]. 
Endocytosis was demonstrated to be a prerequisite for the 
delivery to the vacuole of several plasma membrane proteins, 
including the Ste2 and Ste3 mating pheromone receptors [9,10], 
the Fur4 uracil permease [11], the Itrl inositol permease [12] 
and the Ste6 a-factor pheromone transporter [13,14]. 
Interestingly, it was recently demonstrated that the short- 
lived Ste6 ABC transporter accumulates in a ubiquitinated 
form in the plasma membrane of conditional endocytosis mu- 
tants [13]. Ubiquitin, a polypeptide of 76 amino acids that is 
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covalently attached to protein substrates via an isopeptide bond 
between its a-carboxyl group amino acid and lysine e-amino 
groups of appropriate acceptor proteins, is required for the 
degradation of certain short-lived soluble proteins (reviewed in 
[15]). The proteolytic breakdown of multi-ubiquitinated pro- 
teins is mediated by the 26S proteasome, a ATP-dependent 
multicatalytic enzyme complex containing the 20S proteasome 
as the catalytic ore particle, found both in the cytoplasm and 
the nucleus of eukaryotic ells (reviewed in [16,17]). In yeast, 
several examples of multi-ubiquitinated, soluble proteins or 
proteins whose turnover equires a functional proteasome have 
been reported. For instance, turnover of the transcription fac- 
tor MATch2 [18], the yeast cyclins Cln2 [19], Cln3 [20] and Clb2 
[21], the Gcn4 transcriptional regulator [22], and the fructose- 
1,6-bisphosphatase [23] is mediated by the ubiquitin/pro- 
teasome pathway. 
The existence of ubiquitinated membrane proteins such as 
the mammalian T cell antigen receptor [24] and the cystic fibro- 
sis transmembrane conductance regulator (CFTR) [25] was 
recently demonstrated. Interestingly, the proteolytic break- 
down of the immature, endoplasmic reticulum-localized 
CFTR, as well as a mutated yeast endoplasmic reticulum mem- 
brane protein, Sec61, depends on a functional ubiquitin/pro- 
teasome pathway [25-27]. However, ubiquitin-protein conju- 
gates of membranous origin have also been detected in vacuoles 
of yeast cells lacking vacuolar proteinases [28]. Likewise, immu- 
noelectron microscopy [29,30] and subcellular fractionation 
studies [31] showed that both ubiquitin and ubiquitinated pro- 
teins are found in lysosomes of mammalian cells. Strikingly, 
upon ligand binding, the mammalian platelet-derived growth 
factor receptor-fl was shown to be subject o multi-ubiquitina- 
tion, followed by endocytosis and subsequent delivery to the 
lysosomes for degradation [32]. 
As we have previously shown that the turnover of the short- 
lived yeast plasma membrane transporter Pdr5 requires a func- 
tional vacuole [2], we have set out to identify potential signals 
responsible for vacuolar delivery of Pdr5. In this report, we 
show that the Pdr5 plasma membrane ABC transporter is ubiq- 
uitinated both in wild type and in end4 endocytosis mutants. 
Interestingly, the long-lived plasma membrane ATPase Pmal 
is not ubiquitinated under the same conditions. These results 
suggest a novel role for ubiquitin in protein trafficking within 
the yeast endocytic pathway, in addition to its established func- 
tion in the degradation of multi-ubiquitinated proteins medi- 
ated by the proteasome. 
2. Materials and methods 
2.1. Media, culture conditions and strain construction 
Rich medium (YPD) and synthetic media supplemented with 
auxotrophic omponents o maintain plasmids were prepared essen- 
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tially as described elsewhere [33]. Cultures were grown at 24°C except 
where otherwise indicated. Overproduction fubiquitin under the con- 
trol of the CUP1 promoter was induced by adding CuSO4 to 100 yM 
final concentration. The S. cerevisiae strains YAL21 ( MA Ta ade2- I "C 
his leu2 trpl-1 ura3) and YAL22 (MATa ade2-1 °c his3-11,-15 leu2 trpl-I 
ura3 end4) used in this study were isogenic segregants obtained from 
a cross between CB005 (MATer canl-lO0 ade2-1 °c his3-11,-15 leu2-3.- 
112 trpl-1 ura3-;1 Apep4::LEU2) (obtained from R. Fuller) and 
RH268-1C (MATa his4 leu2 ura3 barl-1 end4) [34]. 
2.2. Plasmids 
The 2 p-based ubiquitin expression vector YEp96 containing a syn- 
thetic yeast ubiquitin gene under the control of the CUP1 promoter, 
and the corresponding plasmid YEpI05 with an additional c-myc epi- 
tope at the N-terminus of the ubiquitin gene, were previously described 
[35]. Plasmid pYKS18 carrying a Haemophilus influenza hemeag- 
glutinin (HA) epitope-tagged PDR5 gene was described elsewhere [4]. 
Transformation of yeast cells used standard methods [33]. 
2.3. Antisera 
The generation of polyclonal rabbit antibodies against a glutathione- 
S-transferase-Pdr5 fusion protein that contained 183 amino acids of the 
N-terminal part of Pdr5 (amino acids 4-187) was described elsewhere 
[2]. The polyclonal antiserum against fatty acid synthase (Fas) complex 
was raised in rabbits using SDS-denatured fatty acid synthase purified 
from yeast [36]. Anti-Ste6 antiserum #9384 used for immunoprecipita- 
tion and anti-Ste6 antibodies for immunoblots were described else- 
where [13,37]. Monoclonal antibodies recognizing the c-myc epitope 
and the HA epitope were previously described, respectively [38,39]. 
Polyclonal anti-Pmal antiserum #838 was kindly provided by R. Ser- 
rano. 
2.4. Yeast cell extracts, immunoprecipitation and immunoblotting 
40D600 equivalents of cells were harvested and washed once with 
cold 10 mM NAN3. After repelleting, the cells were resuspended in 50 
pl cold breaking buffer (50 mM Tris-HC1, pH 7.6, 1 mM EDTA, 1 mM 
phenylmethansulfonylfluoride, 5 mM N-ethyl maleimide) and an equal 
volume of cold glass beads was added. Cell lysis was achieved by 
vortexing the mixture 4 times for 1 min with 1 rain on ice in between. 
After adding 50 pl breaking buffer containing 2% SDS, cell lysis was 
continued for another 2 min and the cell extracts were cleared by 
centrifugation at 13,000 x g for 5 min. 
For immunoblotting, 10/.tl lysate were diluted l-fold with sample 
buffer (40 mM Tris-HC1, pH 6.8, 8 M urea, 5% SDS, 0.1 mM EDTA, 
2% fl-mercaptoethanol, 0.01% bromphenol blue) and heated at 37°C 
for 10 min. The proteins were resolved by SDS-PAGE on a 7.5% gel 
and transferred to nitrocellulose membranes as previously described 
[37]. Membranes were incubated for 1 h in blocking buffer (25 mM 
Tris-HCl, pH 7.4, 140 mM NaC1, 5% fat-free dry milk, 0.1% Triton 
X-100, 10 mM NAN3) and proteins on immunoblots were visualized 
using the ECL chemoluminescence detection [40]. Antisera dilutions in 
10 ml blocking buffer were 1/20,000 for anti-Pdr5, 1/10,000 for anti-Fas, 
1/5,000 for anti-Ste6, 1/30,000 for anti-Pmal and 1/10,000 for monoclo- 
nal anti-c-myc 9El0 antibodies. Goat anti-rabbit and goat anti-mouse 
horseradish peroxidase conjugates (Oncogene Science) were used as 
secondary antibodies at a 1/10,000 dilution. 
For immunoprecipitation, extracts were diluted with 20 vols. of IP 
buffer (50 mM Tris-HC1, pH 7.5, 150 mM NaC1, 4 mM EDTA, 1% 
Triton X-100, 2 mM NAN3) and insoluble material was removed by 
centrifugation (13,000 × g, 10 min). Polyclonal anti-Ste6 (#9384, 1/200), 
anti-Fas (1/200), anti-Pmal (1/400) or monoclonal anti-HA 12CA5 
antibodies (1/200) were added to the supernatant and immunoprecipita- 
tion was performed as previously described [37]. Immunoprecipitates 
corresponding to 10D600 of cells were loaded onto a 7.5% SDS poly- 
acrylamide gel and subjected to immunoblotting asdescribed above. 
3. Results 
3.1. The plasma membrane protein Pdr5 is ubiquitinated 
To elucidate a potential role for ubiquit in in the endocytosis 
of the Pdr5 mult idrug transporter, we have employed a func- 
t ional c-myc epitope-tagged version of ubiquit in [35]. Ceils of 
the wild type YAL21 and the end4 mutant  strain YAL22, both 
of which carrying plasmid pYKS18 containing a HA-tagged 
variant of Pdr5 that is functionally indistinguishable from au- 
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Fig. 1. The integral plasma membrane protein Pdr5 is ubiquitinated in vivo. Strain YAL21 [pYKSI8] harboring a HA-tagged Pdr5 gene was 
transformed either with plasmid YEp96 carrying a ubiquitin gene (Ub) or plasmid YEp105 containing a c-myc tagged version of ubiquitin (mycUb). 
(A) Total protein extracts of strains YAL21 [pYKS18 YEp96] and YAL21 [pYKS18 YEpI05] corresponding to 0.40D600 cells were separated by 
SDS-PAGE on a 7.5% gel and analyzed by immunoblotting with polyclonal anti-Pdr5 antiserum and monoclonal anti-c-myc 9El0 antibodies. (13) 
Cell lysates of strains YAL21 [pYKS 18 YEp96] and YAL21 [pYKSI8 YEp105] corresponding to 10D600 of cells were subjected to immunoprecip- 
itation as described in section 2. Immunoprecipitates (IP) of Pdr5 with monoclonal anti-HA 12CA5 antibodies were analyzed on immunoblots with 
polyclonal anti-Pdr5 antiserum and for ubiquitination with anti-c-myc 9El 0 antibodies, respectively. (C) Cell lysates were subjected to immunoblotting 
with anti-Fas antiserum against fatty acid synthase complex (Fas). Immunoprecipitates (IP) of Fas were analyzed on immunoblots with anti-c-myc 
9El0 antibodies. 
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Fig. 2. Pdr5 and Ste6, but not Pmal, are ubiquitinated in wild type and 
in end4 mutants. Cells of wild type strain YAL21 [pYKS18 YEpl05] 
and end4 mutant strain YAL22 [pYKS 18 YEp 105] were grown at 24°C 
to an 0D600 of 1.5. Ubiquitin expression was induced with CuSO4 30 
rain before shifting cells to 37°C for 1.5 h. Cell lysis and immunoprecip- 
itation were performed as described above. (A) Analysis of cell lysates 
from END4 wild type and end4 mutant cells on immunoblots for Pdr5 
(anti-Pdr5) and ubiquitinated proteins (anti-c-myc 9El0). (B) Im- 
munoprecipitation of HA-tagged Pdr5 of END4 wild type and end4 
mutant cells with anti-HA 12CA5 antibodies. Detection of Pdr5 and 
ubiquitinated P r5 in the immunoprecipitates (IP) was performed by 
immunoblotting with anti-Pdr5 and anti-c-myc 9El0 antibodies, re- 
spectively. (C) Immunodetection f Ste6 and Pmal in cell lysates of 
END4 wild type and end4 mutant cells (anti-Ste6 or anti-Pmal). 
(D) Visualization of ubiquitinated Ste6 after immunoprecipitation of 
the protein (antiserum #9384) and blotting of Pmal immunoprecipi- 
tates (antiserum #838) with anti-c-myc 9El0 antibodies, respectively. 
thentic Pdr5 [2,4], were transformed with either ubiquitin ex- 
pressing plasmid YEp96 or with YEpl05 expressing the c-myc 
tagged version of ubiquitin under the control of the CUP1 
promoter. Cells were grown in synthetic medium to an 006o  o 
of 1.5 and the expression of plasmid-encoded ubiquitin was 
induced by adding Cu 2+ ions for 60 min before harvesting cells. 
Cell lysates were prepared and the levels of Pdr5 and ubiquitin 
expression were determined by immunoblotting with anti-Pdr5 
antiserum and anti-c-myc 9El0 antibodies, respectively (Fig. 
1A). 
Equal amounts of Pdr5 protein were found in the control 
cells carrying the ubiquitin plasmid (YEp96; Ub) and in the 
transformant containing the c-myc tagged ubiquitin (YEpl05; 
mycUb). Further, the c-myc 9El0 antibodies recognized no 
proteins in the total lysate of the control cells (Ub), except one 
faint single band of low molecular mass. In the c-myc ubiquitin 
expressing cells (mycUb), a ladder of bands over the entire 
molecular mass spectrum was detectable, reflecting cellular 
proteins covalently conjugated to c-myc tagged ubiquitin. 
Next, HA-tagged Pdr5 from cell lysates of the control trans- 
formant (Ub) and the cells containing c-myc ubiquitin (mycUb) 
was immunoprecipitated with monoclonal anti-HA 12CA5 an- 
tibodies and analyzed on immunoblots with polyclonal anti- 
Pdr5 antiserum and anti-c-myc 9El0 antibodies (Fig. 1B). Total 
HA-tagged Pdr5 was detectable in same amounts in the control 
transformant (Ub) and in the cells with c-myc tagged ubiquitin 
(mycUb). In contrast, when analyzed for ubiquitinated proteins 
with c-myc 9El0 antibodies, only a signal for the c-myc ubiq- 
uitin containing cells corresponding to the molecular mass of 
Pdr5 including a smear to higher molecular mass was detected. 
Since the anti-c-myc 9El0 antibody recognizes only proteins 
that are covalently conjugated to c-myc ubiquitin, Pdr5 must 
therefore be linked to ubiquitin, demonstrating that the Pdr5 
belongs to a subclass of plasma membrane proteins that is a 
target for ubiquitination i vivo. 
In a further control experiment, we immunoprecipitated he
~z and fl subunits of the fatty acid synthase (Fas), a soluble and 
long-lived cz6B 6 enzyme complex of the cytoplasm [36]. As 
shown in Fig. 1C, no ubiquitination of the Fas complex was 
detectable on the immunoblot when probed with anti-c-myc 
9El0 antibodies. The ability of the anti-Fas antibodies to im- 
munoprecipitate he Fas complex was verified in a separate 
experiment with 35S-radiolabelled Fas (data not shown). 
3.2. Pdr5 and Ste6, but not Pmal, are ubiquitinated prior to 
endocytosis 
To test if Pdr5 ubiquitination requires a functional endocytic 
pathway, we compared the formation of Pdr5-ubiquitin conju- 
gates in the wild type strain YAL21 (END4 [pYKS18 YEpl05]) 
and the endocytosis mutant YAL22 (end4 [pYKS18 YEpl05]), 
both of which carried the plasmids with HA-tagged Pdr5 and 
the c-myc tagged ubiquitin. After growing the cells to an OD600 
of 1.5, the expression of ubiquitin was induced by adding 
CuSO 4 to 100 mM for 30 min before shifting the cells for 90 
rain to the restrictive temperature of 37°C. The expression 
levels of Pdr5 and the total amounts of ubiquitinated proteins 
were measured in the cell lysates of wild type and end4 mutants 
(Fig. 2A). Pdr5 was again immunoprecipitated with monoclo- 
hal anti-HA 12CA5 antibodies, followed by immunoblotting of
the precipitated protein using polyclonal anti-Pdr5 antibodies. 
As shown in Fig. 2B (right panel), the amount of ubiquitinated 
Pdr5 appeared to be nearly the same in the wild type END4 cells 
and the end4 mutant cells. However, the ratio of ubiquitinated 
Pdr5 (Fig. 2B, right panel) to total Pdr5 (Fig. 2B, left panel) was 
higher in the end4 mutant at the restrictive temperature than 
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the same ratio for the END4 wild type. Hence, this showed 
accumulation of ubiquitinated Pdr5 in the end4 mutant after 
blocking endocytosis, suggesting a function for ubiquitin in 
mediating endocytosis of Pdr5. 
The Ste6 a-factor transporter was the first yeast membrane 
protein shown to be ubiquitinated [13]. Ubiquitinated Ste6 ac- 
cumulates at the plasma membrane of end4 mutants at the 
restrictive temperature [13], where it is stabilized against prote- 
olysis [14]. Thus, as a positive control, we have also im- 
munoprecipitated Ste6 from the same wild type and end4 mu- 
tant lysates using polyclonal anti-Ste6 antibodies (serum 
#9384). Ste6-ubiquitin conjugates were then detected on im- 
munoblots using anti-c-mye 9El0 antibodies (Fig. 2D). In the 
wild type strain, ubiquitinated Ste6 was nearly undetectable. 
However, in the end4 mutant, Ste6-ubiquitin conjugates of 
higher molecular mass were drastically enriched after blocking 
the endocytic pathway for 1.5 h. The apparent immunoreactive 
smear to higher molecular mass could indicate multi-ubiquiti- 
nation of Ste6. To control for Ste6 expression levels, Ste6 was 
also immunodetected in total extracts from both the wild type 
and the end4 mutant as shown in Fig. 2C. 
Ste6 and Pdr5, both of which are rather short-lived proteins 
and degraded in the vacuole, are ubiquitinated membrane pro- 
teins in yeast. To test if a long-lived cell surface protein such 
as the plasma membrane ATPase Pmal is also subject o cowl- 
lent ubiquitination modification, we have also analyzed 
whether or not Pmal is ubiquitinated (Fig. 2C and D). How- 
ever, Pmal, which has a half-life of more than 10 h [41], was 
not ubiquitinated under the experimental conditions used, since 
c-myc 9El0 antibodies did not allow for detection of any im- 
munoprecipitated Pmal (Fig. 2D). The capability of anti-Pma 1
antiserum #838 for immunoprecipitation was tested with 
35S-labeled Pmal in a separate xperiment (data not shown). 
These results provide evidence that long-lived plasma mem- 
brane proteins uch as Pmal are not subject o a post-transla- 
tional ubiquitin modification, and suggest a novel function for 
ubiquitin in promoting or facilitating the endocytic delivery of 
a subset of cell surface proteins to the vacuole for terminal 
degradation. 
4. Discussion 
The Pdr5 multidrug transporter and the Ste6 a-factor phero- 
mone transporter are both membrane proteins of the ABC 
transporter superfamily [7]. As shown in this report, the prote- 
olytic turnover of these transporters appears to involve a ubiq- 
uitin modification, because both Pdr5 and Ste6 are ubiquiti- 
nated prior to endocytosis and vacuolar degradation. It was 
previously shown that the turnover of both Ste6 and Pdr5 does 
not depend on the ubiquitin/proteasome pathway, since the 
half-lifes of neither Ste6 (R. Egner and K. Kuchler, unpub- 
lished results) nor Pdr5 [2] are affected in proteasomal prel-I 
and prel-1 pre2-1 mutants. A drastic metabolic stabilization of 
Ste6 [13,14] and Pdr5 [2] can only be brought about by impaired 
proteolytic activities of the vacuole or by blocking endocytosis. 
Furthermore, as in the case of Ste6, mutations in genes encod- 
ing ubiquitin conjugating enzymes (ubc4 ubc5) also lead to an 
increased metabolic stability of Ste6 [13]. 
Pdr5- and Ste6--ubiquitin conjugates accumulate at different 
rates in the plasma membrane of end4 mutants at the restrictive 
temperature (Fig. 2B and D), which most likely reflects the 
different cellular localization of Ste6 and Pdr5 in the steady 
state. While Pdr5 is a resident plasma membrane protein [2], 
Ste6 is mainly associated with an intracellular, Golgi-like com- 
partment [13,14]. If ubiquitination of Ste6 takes place at the cell 
surface, where Ste6 is found only transiently en route to the 
vacuole [13], an endocytic block would result in a significant 
accumulation of ubiquitinated Ste6 at the cell surface. Indeed, 
while ubiquitin-modified Ste6 was detectable only at very low 
levels in the wild type strain, presumably because of low steady 
state levels of Ste6 in the plasma membrane, Ste6-ubiquitin 
conjugates massively accumulated in the end4 mutant at the 
restrictive temperature (Fig. 2D). In contrast, Pdr5 seems to be 
permanently available for ubiquitination, since Pdr5 was al- 
ready found in the ubiquitinated state in the wild type strain, 
and because Pdr5 is localized in the plasma membrane in the 
steady state (Fig. 2B). The Pdr5 half-life of 60-90 rain [2] is 
about six-fold higher than the one of Ste6, which was deter- 
mined to be about 10-15 min [13], providing a plausible xpla- 
nation for our observation that blocking the endocytic pathway 
for 90 min did not result in a drastic accumulation of Pdr5- 
ubiquitin conjugates (Fig. 2B). 
Ubiquitin-protein conjugates of membranous origin were 
previously found in the vacuole of yeast cells deficient in vacu- 
olar proteolysis [28]. Besides the ubiquitinated membrane 
proteins Pdr5 and Ste6, the Ste2 and Ste3 mating pheromone 
receptors [9,10] and the Fur4 uracil permease [11] are also 
endoeytosed for degradation i the vacuole. Although endocy- 
tosis signals are still ill-defined, a potential signal for regulated 
endocytosis was identified in the Ste2 c~-factor pheromone re- 
ceptor in the C-terminal sequence DAKSS [10]. Deletion of the 
C-terminal tail of Ste2 up to amino acid 345 and a simultaneous 
amino acid exchange to DARSS leads to a complete lack of 
regulated Ste2 endocytosis [10]. In the case of the Fur4 uracil 
permease, a 'destruction box' like nine amino acid sequence, 
which was originally found in the sea urchin B cyclin as a signal 
for protein ubiquitination [42], is believed to be required for 
ubiquitination and endocytosis. A point mutation in this se- 
quence stabilizes Fur4 against degradation under nutritional 
stress conditions [43]. Interestingly, it was recently demon- 
strated that N-starvation-induced metabolic instability of Fur4, 
depends on a functional NPI1 gene that encodes a E3-type 
ubiquitin protein ligase [44] closely related to a family of mam- 
malian E6-AP ubiquitin-protein l gases [45]. Indeed, consistent 
with our idea that ubiquitination can trigger endocytosis, Fur4 
was recently also shown to be ubiquitinated and delivered to 
the vacuole in response to N-starvation (R. Hagenuauer-Tsa- 
pis, personal communication). 
Taken together, these results and our data provide evidence 
that a covalent ubiquitin modification can not only function as 
a signal for protein degradation by the 26S proteasome [15], but 
could also trigger the vacuolar delivery and subsequent turn- 
over of short-lived plasma membrane proteins in yeast. Thus, 
it is tempting to speculate that ubiquitination of yeast mem- 
brane proteins may be a signal for membrane protein traffick- 
ing and/or for the remodeling of the cell surface in general. A 
possible functional role for ubiquitin in the yeast endocytic 
pathway was indeed suggested by the earlier observation that 
overexpression f ubiquitin suppresses the lethality of certain 
clathrin-deficient yeast strains [46]. It will be important to iden- 
tify the signals required for the ubiquitination of ABC trans- 
porters such as Pdr5 and Ste6 and other plasma membrane 
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proteins, and to determine if differences in ubiquitination pat- 
terns and/or multi-ubiquitination [47] determine the life-span 
of proteins and target proteins for either vacuolar or pro- 
teasomal turnover. 
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